Citadel Advisors
LUMO

Citadel Advisors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-18,745
Closed -$43.5K 6953
2024
Q2
$43.5K Buy
18,745
+5,459
+41% +$12.7K ﹤0.01% 5223
2024
Q1
$37.5K Buy
+13,286
New +$37.5K ﹤0.01% 5391
2023
Q2
Sell
-15,548
Closed -$52.7K 6628
2023
Q1
$52.7K Sell
15,548
-2,343
-13% -$7.94K ﹤0.01% 5146
2022
Q4
$64.6K Buy
+17,891
New +$64.6K ﹤0.01% 5187
2022
Q2
Sell
-11,339
Closed -$107K 7094
2022
Q1
$107K Buy
+11,339
New +$107K ﹤0.01% 5623
2021
Q4
Sell
-11,869
Closed -$113K 7356
2021
Q3
$113K Buy
+11,869
New +$113K ﹤0.01% 5789
2020
Q1
Sell
-30,293
Closed -$77K 5425
2019
Q4
$77K Sell
30,293
-1,262
-4% -$3.21K ﹤0.01% 4335
2019
Q3
$50K Sell
31,555
-14,673
-32% -$23.3K ﹤0.01% 4360
2019
Q2
$68K Buy
46,228
+16,295
+54% +$24K ﹤0.01% 4314
2019
Q1
$58K Buy
29,933
+15,762
+111% +$30.5K ﹤0.01% 4200
2018
Q4
$22K Sell
14,171
-31,029
-69% -$48.2K ﹤0.01% 4246
2018
Q3
$108K Sell
45,200
-29,163
-39% -$69.7K ﹤0.01% 3885
2018
Q2
$354K Sell
74,363
-8,487
-10% -$40.4K ﹤0.01% 3340
2018
Q1
$601K Buy
82,850
+1,967
+2% +$14.3K ﹤0.01% 2800
2017
Q4
$656K Buy
80,883
+59,299
+275% +$481K ﹤0.01% 2662
2017
Q3
$220K Sell
21,584
-168,804
-89% -$1.72M ﹤0.01% 3156
2017
Q2
$1.4M Buy
190,388
+138,249
+265% +$1.02M ﹤0.01% 1922
2017
Q1
$1.26M Buy
+52,139
New +$1.26M ﹤0.01% 1953
2016
Q4
Hold
0
4203
2016
Q3
Hold
0
4180
2016
Q2
Hold
0
4001
2016
Q1
Sell
-1,988
Closed -$72K 4066
2015
Q4
$72K Sell
1,988
-52,780
-96% -$1.91M ﹤0.01% 3345
2015
Q3
$1.96M Buy
54,768
+52,600
+2,426% +$1.89M ﹤0.01% 1750
2015
Q2
$96K Sell
2,168
-94,010
-98% -$4.16M ﹤0.01% 3278
2015
Q1
$5.26M Buy
96,178
+72,953
+314% +$3.99M 0.01% 1248
2014
Q4
$923K Buy
23,225
+18,563
+398% +$738K ﹤0.01% 2163
2014
Q3
$100K Buy
+4,662
New +$100K ﹤0.01% 3066
2014
Q2
Sell
-9,551
Closed -$271K 3788
2014
Q1
$271K Buy
9,551
+174
+2% +$4.94K ﹤0.01% 2668
2013
Q4
$206K Buy
+9,377
New +$206K ﹤0.01% 2471
2013
Q3
Hold
0
3090